Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

50.89
Delayed Data
As of May 26
 +0.14 / +0.28%
Today’s Change
35.72
Today|||52-Week Range
80.00
-35.20%
Year-to-Date

Today’s Trading

Previous close50.75
Today’s open50.92
Day’s range49.89 - 51.48
Volume350,716
Average volume (3 months)551,759
Market cap$1.8B
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)-3.73%
Earnings growth (this year)-58.24%
Earnings growth (next 5 years)--
Revenue growth (last year)+24.83%
P/E ratioNM
Price/Sales52.72
Price/Book29.80

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-0.72-1.62%
NVAXNovavax Inc-0.16-2.77%
RDUSRadius Health Inc-1.25-3.58%
HALOHalozyme Therapeutic...-0.18-1.79%
Data as of 05/26/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$1.15
Annual revenue (last year)$51.5M
Annual profit (last year)-$105.7M
Net profit margin-205.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President &
Vice Chairman
Samir Chandrakant Patel
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs